{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:33:19Z","timestamp":1787322799844,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Pericardial disease represents a diverse clinical spectrum, including acute pericarditis, pericardial effusion, cardiac tamponade, effusive\u2013constrictive pericarditis (CP), and CP, which vary significantly in presentation, urgency, and management. Recent consensus guidelines from the European Society of Cardiology and the American College of Cardiology have enhanced clinical phenotyping, multimodal imaging techniques, and targeted immunomodulatory therapies; however, their implementation in clinical practice remains variable. We introduce our updated pathway-based framework that structures diagnosis and treatment around 5 key clinical scenarios: chest pain, hemodynamic collapse, dyspnea, incidental pericardial effusion, and right-sided heart failure. Each scenario guides a systematic process of risk stratification, tiered diagnostic evaluation, and phenotype-specific therapy. In cases of acute pericarditis, management employs a 3-tier escalation approach, with interleukin-1 inhibitors (rilonacept, anakinra) as the preferred escalation for inflammatory phenotypes unresponsive to nonsteroidal anti-inflammatory drugs and colchicine. Cardiac magnetic resonance imaging is integral to phenotyping, utilizing late gadolinium enhancement and T2-STIR sequences to inform treatment escalation. Management of pericardial effusion is standardized through a validated drainage scoring system that considers etiology, size, and echocardiographic hemodynamics. CP is classified into 3 subtypes: transient\/inflammatory, effusive\u2013constrictive, and chronic\/fixed, each with a distinct management pathway, reserving surgical pericardiectomy at specialized centers for fibrotic or medically refractory cases. This pathway consolidates current evidence into a reproducible clinical framework designed to standardize care, enhance diagnostic precision, and facilitate shared decision-making among multidisciplinary pericardial disease teams.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000432","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:26:06Z","timestamp":1787318766000},"page":"e0432","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pathway for the Diagnosis and Management of Pericardial Disease: Contemporary Perspective"],"prefix":"10.1097","volume":"25","author":[{"given":"Sanjay","family":"Sivalokanathan","sequence":"first","affiliation":[{"name":"Mount Sinai Morningside, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Herzog","sequence":"additional","affiliation":[{"name":"Hadassah Hebrew University Medical Center, Jerusalem, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Waqas","family":"Haider","sequence":"additional","affiliation":[{"name":"MedStar Washington Hospital Center, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Argulian","sequence":"additional","affiliation":[{"name":"Mount Sinai Morningside, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"R1-20260821","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.jacc.2025.05.023","article-title":"2025 concise clinical guidance: an ACC Expert Consensus Statement on the diagnosis and management of pericarditis.","volume":"86","author":"Wang","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"R2-20260821","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC Guidelines for the management of myocarditis and pericarditis.","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"},{"key":"R3-20260821","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/HPC.0b013e31821644bb","article-title":"Novel \u201cCHASER\u201d pathway for the management of pericardial disease.","volume":"10","author":"Argulian","year":"2011","journal-title":"Crit Pathw Cardiol"},{"key":"R4-20260821","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/heartjnl-2014-306362","article-title":"Diagnosis and treatment of pericarditis.","volume":"101","author":"Imazio","year":"2015","journal-title":"Heart"},{"key":"R5-20260821","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1056\/NEJMcp1404070","article-title":"Clinical practice. Acute pericarditis.","volume":"371","author":"LeWinter","year":"2014","journal-title":"N Engl J Med"},{"key":"R6-20260821","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.106.662114","article-title":"Indicators of poor prognosis of acute pericarditis.","volume":"115","author":"Imazio","year":"2007","journal-title":"Circulation"},{"key":"R7-20260821","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.amjcard.2014.05.018","article-title":"A structured, parsimonious approach to establish the cause of moderate-to-large pericardial effusion.","volume":"114","author":"Agarwal","year":"2014","journal-title":"Am J Cardiol"},{"key":"R8-20260821","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: results of the COPE trial.","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"key":"R9-20260821","article-title":"Pericarditis in athletes: approach to exercise restriction.","author":"Sivalokanathan","year":"2022","journal-title":"Amer Coll Cardiol"},{"key":"R10-20260821","doi-asserted-by":"crossref","first-page":"e032516","DOI":"10.1161\/JAHA.123.032516","article-title":"Sustained pericarditis recurrence risk reduction with long-term rilonacept.","volume":"13","author":"Imazio","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"R11-20260821","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis (RHAPSODY).","volume":"384","author":"Klein","year":"2021","journal-title":"N Engl J Med"},{"key":"R12-20260821","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamacardio.2022.2584","article-title":"Advances in imaging and targeted therapies for recurrent pericarditis: a review.","volume":"7","author":"Kumar","year":"2022","journal-title":"JAMA Cardiol"},{"key":"R13-20260821","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial.","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"},{"key":"R14-20260821","doi-asserted-by":"crossref","first-page":"102774","DOI":"10.1016\/j.jacadv.2026.102774","article-title":"Interleukin-1 blockade with rilonacept in recurrent pericarditis: tapering and discontinuation in real-world practice.","volume":"5","author":"Marchetta","year":"2026","journal-title":"JACC Adv"},{"key":"R15-20260821","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/eurheartj\/ehs372","article-title":"Management of pericardial effusion.","volume":"34","author":"Imazio","year":"2013","journal-title":"Eur Heart J"},{"key":"R16-20260821","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1161\/01.CIR.90.5.2375","article-title":"Cardiac tamponade complicating proximal aortic dissection: is pericardiocentesis harmful?","volume":"90","author":"Isselbacher","year":"1994","journal-title":"Circulation"},{"key":"R17-20260821","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1161\/CIRCULATIONAHA.111.082685","article-title":"Impact of controlled pericardial drainage on critical cardiac tamponade with acute type A aortic dissection.","volume":"126","author":"Hayashi","year":"2012","journal-title":"Circulation"},{"key":"R18-20260821","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMra022643","article-title":"Acute cardiac tamponade.","volume":"349","author":"Spodick","year":"2003","journal-title":"N Engl J Med"},{"key":"R19-20260821","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/hrt.2003.024810","article-title":"Pericardial effusion: haemodynamic spectrum.","volume":"90","author":"Shabetai","year":"2004","journal-title":"Heart"},{"key":"R20-20260821","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.amjcard.2012.05.042","article-title":"Paradoxical hypertension in patients with cardiac tamponade.","volume":"110","author":"Argulian","year":"2012","journal-title":"Am J Cardiol"},{"key":"R21-20260821","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/HPC.0b013e318254a5ca","article-title":"A novel pericardial effusion scoring index to guide decision for drainage.","volume":"11","author":"Halpern","year":"2012","journal-title":"Crit Pathw Cardiol"},{"key":"R22-20260821","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0025-6196(11)64888-X","article-title":"Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique.","volume":"73","author":"Tsang","year":"1998","journal-title":"Mayo Clin Proc"},{"key":"R23-20260821","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcmg.2024.04.010","article-title":"Pericardial diseases: international position statement on new concepts and advances in multimodality cardiac imaging.","volume":"17","author":"Klein","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"R24-20260821","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacc.2007.09.039","article-title":"Constrictive pericarditis in the modern era: novel criteria for diagnosis in the cardiac catheterization laboratory.","volume":"51","author":"Talreja","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R25-20260821","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jacc.2024.05.048","article-title":"Pericardial diseases and best practices for pericardiectomy: JACC state-of-the-art review.","volume":"84","author":"Al-Kazaz","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"R26-20260821","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/01.CIR.100.13.1380","article-title":"Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy.","volume":"100","author":"Ling","year":"1999","journal-title":"Circulation"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HPC.0000000000000432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:26:09Z","timestamp":1787318769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/HPC.0000000000000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000432","relation":{},"ISSN":["1535-2811"],"issn-type":[{"value":"1535-2811","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]}}}